Application of genetic testing to define the surgical approach in a sporadic case of multiple endocrine neoplasia type 1;Aplicação de teste genético para definição da conduta cirúrgica num caso esporádico de neoplasia endócrina múltipla do tipo 1

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 8, 2010, Pages 705-710

  Boguszewski, Cesar Luiz ^a   Bianchet, Leila Caroline ^a   Raskin, Salmo ^b   Nomura, Luiz M ^c   Borba, Luis Alencar ^a   Cavalcanti, Teresa Cristina Santos ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Genetika Laboratory   (Brazil)

^c HOSPITAL NOSSA SENHORA DAS GRAÇAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MEN1 PROTEIN, HUMAN; ONCOPROTEIN;

ADENOMA; ADULT; ARTICLE; CASE REPORT; CUSHING DISEASE; DECISION MAKING; FEMALE; GENETIC SCREENING; GENETICS; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; SCINTISCANNING; STANDARD;

ADENOMA; DECISION MAKING; FEMALE; GENETIC TESTING; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PARATHYROID NEOPLASMS; PITUITARY ACTH HYPERSECRETION; PROTO-ONCOGENE PROTEINS; YOUNG ADULT;

EID: 79951972090     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000800007     Document Type: Article

References (20)

1. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-71.
2. Hoff AO, Hauache OM. Multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical and molecular diagnosis and treatment of the associated disturbances. Arq Bras Endocrinol Metab. 2005;49:735-46.
3. Burgess J. How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol (Oxf). 2010;72:13-6.
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276(5311):404-7.
5. Hendy GN, Kaji H, Canaff L. Cellular functions of menin. Adv Exp Med Biol. 2009;668:37-50.
6. Vergès B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab. 2002;87:457-65.
7. Corbetta S, Pizzocaro A, Peracchi M, Beck-Peccoz P, Faglia G, Spada A. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types. Clin Endocrinol (Oxf). 1997;47:507-12.
8. Rix M, Hertel NT, Nielsen FC, Jacobsen BB, Hoejberg AS, Brixen K, et al. Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1. Eur J Endocrinol. 2004;151:709-15.
9. Alzahrani AS, Al-Khaldi N, Shi Y, Al-Rijjal RA, Zou M, Baitei EY, et al. Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation. Endocr Pract. 2008;14:595-602.
10. Skandarajah A, Barlier A, Morlet-Barlat N, Sebag F, Enjalbert A, Conte-Devolx B, et al. Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World J Surg. 2010;34:1294-8.
11. Lew JI, Solorzano CC. Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am. 2009;89:1205-25.
12. Waldmann J, López CL, Langer P, Rothmund M, Bartsch DK. Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg. 2010;97(10):1528-34.
13. Raue F, Frank-Raue K. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones (Athens). 2009;8:23-8.
14. Hai N, Aoki N, Shimatsu A, Mori T, Kosugi S. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases without MEN1. Clin Endocrinol (Oxf). 2000;52:509-18.
15. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat. 2008;29:22-32.
16. Gaitan D, Loosen PT, Orth DN. Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1993;76:1580-2.
17. Doherty GM, Lairmore TC, DeBenedetti MK. Multiple endocrine neoplasia type 1 parathyroid adenoma development over time. World J Surg. 2004;28:1139-42.
18. Lourenço DM Jr, Coutinho FL, Toledo RA, Montenegro FL, Correia-Deur JE, Toledo SP. Early-onset, progressive, frequent, extensive and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. J Bone Miner Res. 2010;25(11):2382-91.
19. Light PE. Familial Wolff-Parkinson-White Syndrome: a disease of glycogen storage or ion channel dysfunction? J Cardiovasc Electrophysiol. 2006;17(Suppl 1):S158-61.
20. Nagata D, Hirata Y. The role of AMP-activated protein kinase in the cardiovascular system. Hypertens Res. 2010;33:22-8.